- Annual Meeting
|Invitation to Join the Compendium|
On behalf of the Board of Directors and leadership of the American Society for Experimental Neurotherapeutics (ASENT), I am pleased to invite you to participate in the COMPENDIUM OF EMERGING COMPANIES IN NEUROTHERAPEUTICS.
ASENT is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders. This new initiative is a compilation of companies (<40 FT employees) engaged in developing and commercializing therapies for central nervous system disorders.
The COMPENDIUM will be a gateway for discussion with scientists, investors, businesses, and venture capital. Participation in the COMPENDIUM will include the following:
The requirements: The company must be active in either producing a neurologic-related product (device, drug, or other) or be active in investigation of such a neurologic product.
The rules: Each company will produce a SINGLE PAGE describing the company, the product, and current research progress, if appropriate. A logo is permitted. Please see the attached example of Marinus Pharmaceuticals, Inc.
The cost: $1,000/year.
You will be asked to submit your logo (high res jpg or png), one page summary and payment.
Pay via credit card or check: Checks should made payable to “ASENT” and mailed to
Enclose your check with your one-page summary. Please also email your contact information, logo (high res jpg or png) and one page summary to firstname.lastname@example.org
This COMPENDIUM is a new way to get your company closer to the key stakeholders who need to hear about your product and/or your research. Thank you for your consideration. We look forward to learning more about your company.
Thomas Sutula, MD, PhD